|
Income Taxes (Details) (USD $)
|
12 Months Ended |
|
Dec. 31, 2013
|
Dec. 31, 2012
subsidiary
|
Dec. 31, 2011
|
| Loss before income taxes |
|
|
|
| United States |
$ (20,675,000) |
$ (27,796,000) |
$ (18,429,000) |
| Foreign |
1,319,000 |
486,000 |
(324,000) |
| Loss before provision (benefit) for income taxes |
(19,356,000) |
(27,310,000) |
(18,753,000) |
| Current: |
|
|
|
| Federal |
0 |
4,000 |
(6,000) |
| State |
0 |
0 |
26,000 |
| Foreign |
1,815,000 |
559,000 |
89,000 |
| Deferred: |
|
|
|
| Federal |
159,000 |
(185,000) |
(2,871,000) |
| State |
0 |
(22,000) |
(188,000) |
| Foreign |
81,000 |
32,000 |
31,000 |
| Total provision (benefit) for income taxes |
2,055,000 |
388,000 |
(2,919,000) |
| Reconciliation of provision (benefit) for income taxes that differs from the expected tax benefit computed by applying the statutory federal income tax rates to consolidated loss before income taxes |
|
|
|
| Federal tax at statutory rate |
(6,581,000) |
(9,286,000) |
(6,376,000) |
| State taxes, net of benefit |
0 |
0 |
26,000 |
| Non-deductible expenses |
1,248,000 |
2,416,000 |
1,095,000 |
| Foreign taxes |
1,447,000 |
427,000 |
230,000 |
| Current year net operating losses and other deferred tax assets for which no benefit has been recognized |
7,320,000 |
7,181,000 |
5,448,000 |
| Research and experimentation credit |
(1,379,000) |
0 |
(100,000) |
| Tax benefit due to the recognition of acquired deferred tax liabilities |
0 |
(350,000) |
(3,242,000) |
| Total provision (benefit) for income taxes |
2,055,000 |
388,000 |
(2,919,000) |
| Deferred tax assets |
|
|
|
| Net operating loss carryforwards and deferred start-up costs |
53,902,000 |
47,799,000 |
|
| Accrued expenses and 481(a) |
2,161,000 |
2,737,000 |
|
| Unrealized gain/loss on investments |
915,000 |
894,000 |
|
| Research and experimentation credit carryforwards |
10,884,000 |
9,480,000 |
|
| Capitalized research and experimentation costs |
18,100,000 |
17,617,000 |
|
| Deferred stock compensation |
2,223,000 |
3,651,000 |
|
| Gross deferred tax assets |
88,185,000 |
82,178,000 |
|
| Less valuation allowance |
(86,604,000) |
(78,765,000) |
|
| Total deferred tax assets, net of valuation allowance |
1,581,000 |
3,413,000 |
|
| Deferred tax liabilities |
|
|
|
| Property and equipment |
(1,602,000) |
(3,357,000) |
|
| Goodwill |
(887,000) |
(728,000) |
|
| Net deferred tax assets (liabilities) |
(908,000) |
(672,000) |
|
| Valuation allowance |
|
|
|
| Number of foreign subsidiaries for which there is no valuation allowance on deferred tax assets |
2 |
2 |
|
| Net changes for valuation allowance |
(7,800,000) |
(6,200,000) |
|
| Additional net deferred tax liabilities related to the various acquisitions completed during the year |
0 |
400,000 |
|
|
Federal
|
|
|
|
| Net operating loss carryforwards |
|
|
|
| Outstanding net operating loss carryforwards |
155,900,000 |
|
|
| Expiry period of net operating loss carryforwards, if remained unutilized |
20 years |
|
|
|
California
|
|
|
|
| Net operating loss carryforwards |
|
|
|
| Outstanding net operating loss carryforwards |
$ 44,200,000 |
|
|
| Expiry period of net operating loss carryforwards, if remained unutilized |
20 years |
|
|